The Chosun Ilbo on MSN
L’Oréal expands siRNA collaboration with OliX to nail care
Global beauty giant L’Oréal signed a contract with domestic biotech firm OliX on June 29 to discover ‘short interfering RNA (siRNA)’ substances for nail health. This substance is a core genetic ...
2don MSN
Structural blueprint for RNA therapeutics reveals why some siRNA molecules work better than others
RNA interference is a natural mechanism for living cells to control whether specific genes are being used. Crowned with the ...
RNA interference is a natural mechanism for living cells to control whether specific genes are being used or not.
Cross-kingdom RNA interference encompasses the bidirectional transfer of RNA molecules between plants and their pathogens, enabling one organism to modulate gene expression in another. Fungal and ...
Researchers have discovered RNA mechanisms that may lead to more effective, durable and targeted treatments for conditions like high cholesterol, liver diseases and cancers. RNA interference (RNAi) ...
– Company Expects to Initiate a Phase 1/2 Study for ALN-KHK in Early 2023, with Initial Results Expected in Late 2023 – “We are excited to advance ALN-KHK to the clinic as our first RNAi therapeutic ...
Protecting plants efficiently against pests without harming other organisms—this is the objective of the joint research project ViVe_Beet, which is coordinated by the Julius Kühn Institute (JKI).
Nearly 1.3 billion adults around the world have clinically high blood pressure, many of whom may be unaware that they are living with this condition. Nearly 1.3 billion adults around the world have ...
Pharmaceutical Technology on MSN
AviadoBio broadens vMiX gene silencing licence with King’s College London
The expanded licensing lets AviadoBio pursue partnerships for broader applications, including cardiovascular, nephrology, ...
Gene knockdown is a common method for studying gene function by reducing messenger ribonucleic acid (mRNA) levels without altering the deoxyribonucleic acid (DNA). Among the available techniques, RNA ...
STUART, Fla.--(BUSINESS WIRE)--Cognigenics, a pioneering company in RNA-based therapeutics for neuropsychiatric conditions and neurocognitive disorders, announced the publication of its latest ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results